Diabetes in pregnancy and infant adiposity: systematic review and meta-analysis

Karen M Logan1, Chris Gale1, Matthew J Hyde1

  • 1Section of Neonatal Medicine, Chelsea and Westminster Hospital Campus, Imperial College London, London, UK.

Insights

Infants of mothers with diabetes (IDM) have significantly higher fat mass compared to infants of mothers without diabetes (NIDM). This increased adiposity in IDM, particularly in boys, warrants further investigation into interventions for improved later health outcomes.

Area of Science:

  • Perinatology
  • Pediatric Endocrinology
  • Metabolic Health

Background:

  • Maternal diabetes is linked to increased newborn adiposity.
  • Infants of diabetic mothers (IDM) face higher risks of adverse metabolic health.
  • Adiposity may mediate the metabolic risks in IDM.

Purpose of the Study:

  • To systematically review and meta-analyze adiposity differences between IDM and infants of mothers without diabetes (NIDM).
  • To compare fat mass, fat-free mass, body fat percentage, and skinfold thickness.
  • To analyze subgroups based on maternal diabetes type and infant sex.

Main Methods:

  • Systematic review and random-effects meta-analysis of observational studies.
  • Inclusion of data from 35 papers and over 24,000 infants.
  • Subgroup analyses by maternal diabetes type (type 1, type 2, gestational) and infant sex.
  • Examination of pre-pregnancy body mass index (BMI) influence.

Main Results:

  • IDM exhibited significantly greater fat mass than NIDM (83g difference).
  • Higher fat mass was observed in infants of mothers with gestational diabetes (62g) and type 1 diabetes (268g).
  • Increased fat mass was significant in IDM boys (87g) but not in IDM girls.
  • Results were consistent after adjusting for maternal BMI.

Conclusions:

  • Infants of diabetic mothers demonstrate significantly higher adiposity compared to NIDM.
  • These findings support research into interventions aimed at reducing infant adiposity.
  • Reducing infant adiposity may improve long-term metabolic health outcomes.
Abstract

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...